Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Type 2 DIAbeTes With NAFLD: innOvative Biomarkers of Disease progressioN and clInical outComes

NCT06567990 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT06567990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06567990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Type 2 DIAbeTes With NAFLD: innOvative Biomarkers of Disease progressioN and clInical outComes
Lead sponsor
Hospices Civils de Lyon
Phase
Not applicable
Overall status
Recruiting
Start date
September 25, 2024
Completion date
May 25, 2027
Enrollment
500 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction-associated liver disease